Cerebral Aneurysms Global Clinical Trials Review, H1, 2013

GlobalData''s clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData''s team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215428

Japan Ophthalmic Devices Market Outlook to 2018 - Vision Care, IOL, Cataract Surgery Devices and Others

GlobalData’s new report, “Japan Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others” provides key market data on the Japan Ophthalmic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
- Market size and company share data for Ophthalmic Devices market categories – Cataract Surgery Devices, Glaucoma Surgery Devices, Intraocular Lens (IOL), Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vision Care and Vitreo Retinal Surgery Devices.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Japan Ophthalmic Devicesmarket.
- Key players covered include Hoya Corporation, Essilor International, Bausch & Lomb Incorporated, Alcon, Inc., Johnson & Johnson Vision Care, Inc., CooperVision, Inc. and others.

Buy a copy of this report @ http://www.reportsnreports.com/reports/215453-japan-ophthalmic-devices-market-outlook-to-2018-vision-care-intraocular-lens-iol-cataract-surgery-devices-ophthalmic-diagnostic-equipment-refractive-surgery-devices-vitreo-retinal-surgery-devices-and-others.html

Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Japan Ophthalmic Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents:

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 12
2 Introduction 15
2.1 What is This Report About? 15
3 Ophthalmic Devices In Japan 16
3.1 Ophthalmic Devices, Market Segmentation 16
3.2 Ophthalmic Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 17
3.3 Ophthalmic Devices Market, Japan, Revenue Mix ($m), 2011 19
3.4 Ophthalmic Devices Market, Japan, Category Contribution (%), 2011 20
3.5 Ophthalmic Devices, Japan, Company Share (2010-2011) 27
4 Cataract Surgery Devices In Japan 29
4.1 Cataract Surgery Devices, Market Segmentation 29
4.2 Cataract Surgery Devices Market, Japan, Revenue Mix ($m), 2011 30
4.3 Cataract Surgery Devices Market, Japan, Segment Contribution (%), 2011 31
4.4 Cataract Surgery Devices Overall Revenue, (2004-2018) 32
4.4.1 Ophthalmic Viscoelastic Devices (OVD), Revenue (2004-2018) 36
4.5 Cataract Surgery Devices Overall Volume (2004-2018) 40
4.5.1 Ophthalmic Viscoelastic Devices (OVD), Volume (2004-2018) 42
4.6 Cataract Surgery Devices Average Price (2004-2018) 44
4.7 Cataract Surgery Devices Distribution Share (2010-2011) 45
4.8 Cataract Surgery Devices, Japan, Company Share (2010-2011) 46
5 Glaucoma Surgery Devices In Japan 47
5.1 Glaucoma Surgery Devices Overall Revenue, (2004-2018) 47
5.2 Glaucoma Surgery Devices Overall Volume (2004-2018) 49
5.3 Glaucoma Surgery Devices Average Price (2004-2018) 51
5.4 Glaucoma Surgery Devices Distribution Share (2010-2011) 52
5.5 Glaucoma Surgery Devices, Japan, Company Share (2010-2011) 53
6 Intraocular Lens (IOL) In Japan 54
6.1 Intraocular Lens (IOL), Market Segmentation 54
6.2 Intraocular Lens (IOL) Market, Japan, Revenue Mix ($m), 2011 55
6.3 Intraocular Lens (IOL) Market, Japan, Segment Contribution (%), 2011 56
6.4 Intraocular Lens (IOL) Overall Revenue, (2004-2018) 57
6.4.1 Foldable IOL, Revenue, (2004-2018) 61
6.5 Intraocular Lens (IOL) Overall Volume (2004-2018) 65
6.5.1 Foldable IOL, Volume (2004-2018) 67
6.6 Intraocular Lens (IOL) Average Price (2004-2018) 69
6.7 Intraocular Lens (IOL) Distribution Share (2010-2011) 70
6.8 Intraocular Lens (IOL), Japan, Company Share (2010-2011) 71
7 Ophthalmic Diagnostic Equipment In Japan 72
7.1 Ophthalmic Diagnostic Equipment, Market Segmentation 72
7.2 Ophthalmic Diagnostic Equipment Market, Japan, Revenue Mix ($m), 2011 73
7.3 Ophthalmic Diagnostic Equipment Market, Japan, Segment Contribution (%), 2011 74
7.4 Ophthalmic Diagnostic Equipment Overall Revenue, (2004-2018) 75
7.4.1 Retinal Ultrasound Imaging Systems, Revenue (2004-2018) 79
7.4.2 Ophthalmoscopes, Revenue (2004-2018) 83
7.5 Ophthalmic Diagnostic Equipment Overall Volume (2004-2018) 87
7.5.1 Retinal Ultrasound Imaging Systems, Volume (2004-2018) 91
7.5.2 Ophthalmoscopes, Volume (2004-2018) 94
7.6 Ophthalmic Diagnostic Equipment Average Price (2004-2018) 96
7.7 Ophthalmic Diagnostic Equipment Distribution Share (2010-2011) 98
7.8 Ophthalmic Diagnostic Equipment, Japan, Company Share (2010-2011) 99
8 Refractive Surgery Devices In Japan 101
8.1 Refractive Surgery Devices, Market Segmentation 101
8.2 Refractive Surgery Devices Market, Japan, Revenue Mix ($m), 2011 102
8.3 Refractive Surgery Devices Market, Japan, Segment Contribution (%), 2011 103
8.4 Refractive Surgery Devices Overall Revenue, (2004-2018) 104
8.4.1 Ophthalmic Lasers, Revenue (2004-2018) 108
8.5 Refractive Surgery Devices Overall Volume (2004-2018) 112
8.5.1 Ophthalmic Lasers, Volume (2004-2018) 114
8.6 Refractive Surgery Devices Average Price (2004-2018) 116
8.7 Refractive Surgery Devices Distribution Share (2010-2011) 117
8.8 Refractive Surgery Devices, Japan, Company Share (2010-2011) 118
9 Vision Care In Japan 120
9.1 Vision Care, Market Segmentation 120
9.2 Vision Care Market, Japan, Revenue Mix ($m), 2011 121
9.3 Vision Care Market, Japan, Segment Contribution (%), 2011 122
9.4 Vision Care Overall Revenue, (2004-2018) 123
9.4.1 Contact Lenses, Revenue (2004-2018) 127
9.4.2 Spectacle Lenses, Revenue (2004-2018) 130
9.4.3 Contact Lens Cleaning and Disinfecting Solutions, Revenue (2004-2018) 134
9.5 Vision Care Overall Volume (2004-2018) 136
9.5.1 Contact Lenses, Volume (2004-2018) 140
9.5.2 Spectacle Lenses, Volume (2004-2018) 144
9.5.3 Contact Lens Cleaning and Disinfecting Solutions, Volume (2004-2018) 146
9.6 Vision Care Average Price (2004-2018) 148
9.7 Vision Care Distribution Share (2010-2011) 150
9.8 Vision Care, Japan, Company Share (2010-2011) 151
10 Vitreo Retinal Surgery Devices In Japan 153
10.1 Vitreo Retinal Surgery Devices, Market Segmentation 153
10.2 Vitreo Retinal Surgery Devices Market, Japan, Revenue Mix ($m), 2011 154
10.3 Vitreo Retinal Surgery Devices Market, Japan, Segment Contribution (%), 2011 155
10.4 Vitreo Retinal Surgery Devices Overall Revenue, (2004-2018) 156
10.4.1 Vitreo Retinal Surgery Packs, Revenue (2004-2018) 160
10.5 Vitreo Retinal Surgery Devices Overall Volume (2004-2018) 164
10.5.1 Vitreo Retinal Surgery Packs, Volume (2004-2018) 166
10.6 Vitreo Retinal Surgery Devices Average Price (2004-2018) 168
10.7 Vitreo Retinal Surgery Devices Distribution Share (2010-2011) 169
10.8 Vitreo Retinal Surgery Devices, Japan, Company Share (2010-2011) 170
11 Overview of Key Companies in Japan Ophthalmic Devices Market 171
11.1 Hoya Corporation 171
11.1.1 Company Overview 171
11.1.2 Share in the Japan Ophthalmic Devices Market 171
11.2 Essilor International 172
11.2.1 Company Overview 172
11.2.2 Share in the Japan Ophthalmic Devices Market 172
11.3 Bausch & Lomb Incorporated 173
11.3.1 Company Overview 173
11.3.2 Share in the Japan Ophthalmic Devices Market 173
11.4 Alcon, Inc. 174
11.4.1 Company Overview 174
11.4.2 Share in the Japan Ophthalmic Devices Market 174
11.5 Johnson & Johnson Vision Care, Inc. 175
11.5.1 Company Overview 175
11.5.2 Share in the Japan Ophthalmic Devices Market 175
11.6 CooperVision, Inc. 176
11.6.1 Company Overview 176
11.6.2 Share in the Japan Ophthalmic Devices Market 176
11.7 CIBA Vision Corporation 177
11.7.1 Company Overview 177
11.8 Seiko Optical Products Co., Ltd. 177
11.8.1 Company Overview 177
11.9 Carl Zeiss AG 177
11.9.1 Company Overview 177
11.10 St. Shine Optical Co., Ltd. 178
11.10.1 Company Overview 178
11.11 Abbott Medical Optics, Inc. 178
11.11.1 Company Overview 178
11.12 Topcon Corporation 178
11.12.1 Company Overview 178
11.13 NIDEK CO., LTD. 179
11.13.1 Company Overview 179
11.14 Tomey Corporation 179
11.14.1 Company Overview 179
11.15 STAAR Surgical Company 179
11.15.1 Company Overview 179
11.16 Ellex Medical Lasers Limited 180
11.16.1 Company Overview 180
11.17 Ajinomoto Trading, Inc. 180
11.17.1 Company Overview 180
11.18 Sauflon Pharmaceuticals Limited 180
11.18.1 Company Overview 180
11.19 Ziemer Ophthalmic Systems AG 181
11.19.1 Company Overview 181
11.20 Dutch Ophthalmic Research Center International BV 181
11.20.1 Company Overview 181
11.21 Heine Optotechnik GmbH & Co KG 181
11.21.1 Company Overview 181
11.22 SCHWIND eye-tech-solutions GmbH & Co. KG 182
11.22.1 Company Overview 182
11.23 Haag-Streit AG 182
11.23.1 Company Overview 182
11.24 Lumenis Ltd. 182
11.24.1 Company Overview 182
12 Ophthalmic Devices Market Pipeline Products 183
13 Financial Deals Landscape 187
13.1 Acquisition 187
13.1.1 Hoya To Acquire 30% Stake In Seiko Optical Products From Seiko Holdings 187
13.2 Partnerships 188
13.2.1 Hoya To Enter Into Co-Marketing Agreement With Seiko Holdings 188
13.2.2 Iridex Enters Into Licensing Agreement With Quantel Medical For MicroPulse 189
13.2.3 LightPath Technologies Enters Into Licensing Agreement With Hubei New HuaGuang Information aterials For Gradium 190
14 Recent Developments 191
14.1 Strategy And Business Planning 191
14.1.1 Sep 25, 2012: Santen Pharma To Establish New Sales And Marketing Company In China 191
14.1.2 Sep 07, 2012: Nidek Launches Affiliated Company In Shanghai 191
14.2 Product News 192
14.2.1 Jan 08, 2009: Tomey USA Launches Tomey EM-3000 Specular Microscope 192
15 Appendix 193
15.1 Definitions of Markets Covered in the Report 194
15.1.1 Ophthalmic Devices 194
15.2 Research Methodology 202
15.3 Secondary Research 202
15.4 Primary Research 203
15.5 Models 203
15.6 Forecasts 204
15.7 Expert Panels 204
15.8 GlobalData Consulting 204
15.9 Currency Conversion 205
15.10 Contact Us 205
15.11 Disclaimer 205

Request a Sample @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215453

Global Clinical Trials Review on Bone Metastasis, H1, 2013

GlobalData''s clinical trial report, “Bone Metastasis Global Clinical Trials Review, H1, 2013" provides data on the Bone Metastasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Metastasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Metastasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData''s team of industry experts.

Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Buy a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215426 

Table of Contents 
List of Tables 5
List of Figures 6
Introduction 7
Bone Metastasis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Bone Metastasis 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Bone Metastasis Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Algeta ASA 34
Clinical Trial Overview of Algeta ASA 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Amgen Inc. 36
Clinical Trial Overview of Amgen Inc. 36
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Hoffmann-La Roche Inc. 39
Clinical Trial Overview of Hoffmann-La Roche Inc. 39
Novartis Pharmaceuticals Corporation 40
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Medivir AB 42
Clinical Trial Overview of Medivir AB 42
Insmed Incorporated 43
Clinical Trial Overview of Insmed Incorporated 43
Merck KGaA 44
Clinical Trial Overview of Merck KGaA 44
Galil Medical Ltd. 45
Clinical Trial Overview of Galil Medical Ltd. 45
AstraZeneca PLC 46
Clinical Trial Overview of AstraZeneca PLC 46
Celsion Corporation 47
Clinical Trial Overview of Celsion Corporation 47
Bristol-Myers Squibb Company 48
Clinical Trial Overview of Bristol-Myers Squibb Company 48
Clinical Trial Overview of Top Universities / Institutes / Hospitals 49
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Sun Yat-sen University 50
Clinical Trial Overview of Sun Yat-sen University 50
University Health Network 51
Clinical Trial Overview of University Health Network 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
Massachusetts General Hospital 53
Clinical Trial Overview of Massachusetts General Hospital 53
UMC Utrecht Holding BV 54
Clinical Trial Overview of UMC Utrecht Holding BV 54
Virginia Commonwealth University 55
Clinical Trial Overview of Virginia Commonwealth University 55
Rambam Health Care Campus 56
Clinical Trial Overview of Rambam Health Care Campus 56
Wake Forest University 57
Clinical Trial Overview of Wake Forest University 57
University of Virginia 58
Clinical Trial Overview of University of Virginia 58
FUDAN University 59
Clinical Trial Overview of FUDAN University 59
The University of British Columbia 60
Clinical Trial Overview of The University of British Columbia 60
VU University Medical Center 61
Clinical Trial Overview of VU University Medical Center 61
The University of Texas Health Science Center at San Antonio 62
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 62
National Taiwan University Hospital 63
Clinical Trial Overview of National Taiwan University Hospital 63
Case Comprehensive Cancer Center 64
Clinical Trial Overview of Case Comprehensive Cancer Center 64
Sunnybrook Health Sciences Centre 65
Clinical Trial Overview of Sunnybrook Health Sciences Centre 65
University of Michigan 66
Clinical Trial Overview of University of Michigan 66
Chinese University of Hong Kong 67
Clinical Trial Overview of Chinese University of Hong Kong 67
Queen''s University 68
Clinical Trial Overview of Queen''s University 68
Five Key Clinical Profiles 69
Appendix 142
Abbreviations 142
Definitions 142
Research Methodology 143
Secondary Research 144
About GlobalData 144
Contact Us 144
Disclaimer 144
Source 145

Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215426

Australia Consumer Lending Research Report and Forecast to 2017

Fears of worsening economic conditions abroad coupled with media speculation regarding the emergence of a 2-speed economy persuaded consumers to continue to insulate themselves through efforts to deleverage and accumulate wealth. Consumers remained cautious of debt, choosing fixed over variable interest housing loans, making mortgage payments above those required and switching to debit cards from credit cards in 2012.

Euromonitor International''s Consumer Lending in Australia report establishes the size and structure of the market for ATMs cards, smart cards, credit cards, debit cards, charge cards, pre-paid cards and store cards. It looks at key players in the market (issuers and operators), number of cards in circulation, numbers transactions and value of transactions. It offers strategic analysis of sector forecasts and trends to watch.

Product coverage: Consumer Credit, Mortgages/Housing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Lending market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.


Published: January 2013
No. of Pages: 17
Price: US $  1900

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=215551.

Table of Contents
Executive Summary
Australians Determined To Deleverage
A Shaky Housing Market Limits Mortgages/housing Growth
the Big Four Tighten Their Grip
Reforms Promote Market Confidence
Australia Is A Solid Performer
Key Trends and Developments
Income Growth Lets Saving and Spending Coexist
Housing Sceptics Grow Louder
Australia Puts A Price on Carbon
Market Data
Table 1 Consumer Lending By Category: Outstanding Balance: Value 2007-2012
Table 2 Consumer Lending By Category: Outstanding Balance: % Value Growth 2007-2012
Table 3 Consumer Lending By Category: Gross Lending: Value 2007-2012
Table 4 Consumer Lending By Category: Gross Lending: % Value Growth 2007-2012
Table 5 Consumer Lending: Non-performing Loans 2007-2012
Table 6 Mortgages/Housing: Non-performing Loans 2007-2012
Table 7 Consumer Credit: Non-performing Loans 2007-2012
Table 8 Card Lending: Non-performing Loans 2007-2012
Table 9 Forecast Consumer Lending By Category: Outstanding Balance: Value 2012-2017
Table 10 Forecast Consumer Lending By Category: Outstanding Balance: % Value Growth 2012-2017
Table 11 Forecast Consumer Lending By Category: Gross Lending: Value 2012-2017
Table 12 Forecast Consumer Lending By Category: Gross Lending: % Value Growth 2012-2017
Sources
Summary 1 Research Sources
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 13 Consumer Credit By Category: Outstanding Balance: Value 2007-2012
Table 14 Consumer Credit By Category: Outstanding Balance: % Value Growth 2007-2012
Table 15 Consumer Credit By Category: Gross Lending: Value 2007-2012
Table 16 Consumer Credit By Category: Gross Lending: % Value Growth 2007-2012
Table 17 Forecast Consumer Credit By Category: Outstanding Balance: Value 2012-2017
Table 18 Forecast Consumer Credit By Category: Outstanding Balance: % Value Growth 2012-2017
Table 19 Forecast Consumer Credit By Category: Gross Lending: Value 2012-2017
Table 20 Forecast Consumer Credit By Category: Gross Lending: % Value Growth 2012-2017


Contact sales@reportsandreports.com for further information.

Poland Telecommunications Services Market Research Report

Discover how Polish businesses use telecommunications services. Report reveals high potential services and prognosis for overall growth

In order to provide a more detailed examination of the business services segment, PMR has prepared Telecommunications services for the business segment in Poland 2012 Development forecasts for 2012-2016. This report provides detailed information on specific areas of interest as well as for the overall business services market as it applies to fixed-line telephony, mobile telephony and DLISP (line rental, internet access and data transfer) services.

This document supplies statistical data, insightful analysis and precise forecasts for the business segment of Polish telecommunications, and explores the purchasing habits and spending patterns of Polish businesses in terms of various telecommunications services. It also tracks the visible changes in this segment using historical data accumulated from years of market observation. The expert analysts at PMR have combined information from many sources to evaluate the prospects of telecoms services currently being added and expanded by business clients. They have created a dynamic description of this specialised market and the trends and conditions that influence demand for various services and stimulate overall growth potential.

Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215222.

This report examines fixed line telephony, presenting the total value and lines utilised by Polish businesses, the degree of penetration achieved by the market and the status of the sub-segment of VoIP services among business customers. It provides analysis of the mobile telephony segment, with data on its value and estimates of growth potential and totals of SIM cards used by business customers. It also includes coverage of the business-related DLISP services segment, including growth potential for internet access services, line rental, IP VPN, data transfer services, and collocation and hosting at a time when Polish businesses are investing in mobile and internet technology as their employees expand usage.

The document profiles major telecoms companies that serve Polish businesses, and estimates the overall value of the business telecoms services segment in Poland. It reviews potential customers, and reports on the specific services they use and plan to add in the near future. It describes the service packages that major companies currently provide to business customers and the market trends that will dictate growth in the years ahead while describing the size, value and volume with which the business services segment is expected to grow, and the specific direction that growth will take.

Telecommunications services for the business segment in Poland 2012, Development forecasts for 2012-2016 will enhance the efficiency of business operations of telecoms services and equipment providers, research and consulting services providers focused on this segment and a variety of other professionals with interests in this evolving marketplace

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=215222.

Contact sales@reportsandreports.com for further information.

Global Markets of Aluminium Pipes and Tubes Industry

ReportsnReports adds new market research report "Aluminium Pipes and Tubes - Global Markets Package" to its store.

This market research report package offers a perspective on the actual market situation, trends and future outlook for aluminium pipes and tubes in different countries around the world. The studies provide essential market information for decision-makers including:
- Overall market value for aluminium pipes and tubes in different countries
- Overall market volume for aluminium pipes and tubes in different countries
- Market value and volume for aluminium pipes and tubes by type (Aluminium alloy, not alloyed)
- Product prices
- Forecasts and future outlook of the market
- Country overview, macroeconomic indicators and indicators of doing business

Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=198412.

These market studies answer to questions such as:
- What is the size of the aluminium pipes and tubes markets in different countries around the world?
- How are the markets divided into different types of products? Which products are growing fast?
- How the markets have been developing? How does the future look like?
- What is the potential for the markets?
- How the indicators of doing business look like? For example, how easily the contracts are being enforced, or what is the inflation rate and how is it developing?

Countries included in the package:
Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Iran, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kyrgyzstan, Lithuania, Macedonia, Malaysia, Mexico, Mongolia, Morocco, Nepal, Netherlands, Norway, Oman, Pakistan, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Senegal, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Sweden, Tanzania, Thailand, Turkey, Ukraine, United Kingdom, United States and Vietnam

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=198412.

Contact sales@reportsandreports.com for further information.

Public Safety LTE: A Global Assessment of Market Size, Technology, Vendor Trends and Spectrum Allocation 2013 - 2018

In times of disasters and emergency situations access to reliable, integrated communications and tactical information is absolutely critical. Unfortunately the ability to mount a coordinated inter-agency response to major threats is often hampered by the proliferation of divergent signaling standards and non-aligned spectrum planning.

Considered as the de-facto standard for Public Safety broadband communications, LTE is rapidly gaining momentum within the Public Safety industry. As a result Public Safety agencies, vendors and service provider are heavily investing in Public Safety LTE, with commercial deployments in both the North America and the Middle East region. While initial investments appear promising there still remain a number of key issues that need to be addressed such as frequency spectrum allocation, funding for private LTE network deployments, QoS prioritization of users in commercial networks, and interoperability with legacy Land Mobile Radio (LMR) systems such as APCO 25 and TETRA.

This report provides an in-depth of the global Public Safety LTE industry to address the aforementioned issues, in addition to providing a detail assessment of the technology, market size, and key trends within the Public Safety LTE industry.

The report covers the following topics:

• Global Spectrum Allocation for Public Safety LTE: A global assessment of spectrum allocation and funding for Public Safety LTE deployments, based on input from regional regulatory authorities.
• Global Public Safety LTE Market Size, Contracts & Trials: A global review of the worldwide Public Safety LTE market including assessment of revenue share by market segment (infrastructure sales, services, user device sales, etc), and a review of global contracts and trial engagements.
• RAN Sharing and Roaming: The term “RAN sharing” refers to sharing of actual eNodeBs. As part of this arrangement, each operator accesses the shared RAN with its own EPC. Vendors are also considering the implementation of Inter-PLMN handover (as opposed to roaming) and then for LTE Commercial carriers to deploy Policies for Service Level Agreements that include Priority Access (Access Class Barring, Preemption and ARP) and QoS/ QCI assignment for default and dedicated bearers. The report assesses in detail how many of vendors and commercial carriers will support RAN sharing,  roaming and inter-PLMN handovers which will be  key factors towards the adoption of commercial LTE RANs for Public Safety applications.
• Global QoS Requirements for Public Safety LTE Communications: A detailed assessment of global requirements for Priority access and High QoS for Public Safety subscribers, for shared commercial LTE networks, while they roam on to Commercial Networks.
• Public Safety LTE Devices and End User Applications: An assessment of device usability characteristics, Multi-Radio LTE/LMR interoperability technology, Software and Applications (VoLTE, PTT over LTE, IMS, IP).
• Vendor Trends and Roadmaps: A detailed assessment of solution portfolios and roadmaps for major infrastructure/ device vendors and system integrators
• LTE-Advanced Support for Heterogeneous Commercial/LMR Networks: In-depth assessment of the LTE Advanced standard and technologies and spectrum planning for Fixed/Nomadic based Pico Cells/Femto Cells and mobile base stations (e.g. LTE Cell on Wheels (CoW)) and proximity based services such as Direct Mode Operation (DMO) in LMR systems, which have broad implications for the adoption of Public Safety LTE services.
• LTE based Public Safety Tactical Systems and Military Applications: Detailed market assessment of LTE based Public Safety Tactical Systems such as CoW, Cell over Light Trucks (COLTs) and Military Applications for LTE.

Report Details:
Published: January 2013
No. of Pages: 90
Price:Single User License:US$2995           Single User License:US$6995
 
 
 Key Findings:

• Between 2013 and 2018, the Public Safety LTE market will grow at a CAGR of 43  % accounting for over $ 10 Billion in revenue by 2018, up from $ 1.8 Billion in 2013.
• Operator service revenues will constitute a vast majority of the revenue, followed by managed services and integration, representing a lucrative opportunity for vendors and system integrators to build, own and operate Public Safety LTE networks.
• Europe will lag behind Middle East, Asia Pacific and Latin America in the early adoption of Public Safety LTE technology due to stringent spectrum regulation policies. The Middle East has already witnessed commercialization of the technology with an early deployment by the Qatar MOI.

Target Audience:

• System Integrators
• Public Safety Agencies
• LMR Radio Manufacturers
• Cellular Network Operators
• Smartphone Manufacturers
• Public Safety Network Operators
• LMR Infrastructure Manufacturers
• Public Safety Application Developers
• Mobile Computing Equipment Manufacturers
• Cellular Network Infrastructure Manufacturers

Companies and Organizations in Report:

• 3GPP
• Abu Dhabi Police
• Alcatel Lucent
• APCO
• AT&T
• BayWEB
• Brazilian Army
• Cassidian
• Ericsson
• ETSI
• FCC
• Harris Corporation
• Hong Kong Police
• HTC
• Huawei
• Intrado
• IP Wireless (General Dynamics)
• KPN
• LA-RICS
• Motorola Mobility
• Motorola Solutions
• Nokia Siemens Networks
• Oceus Networks
• Qatar Armed Forces
• Qatar MOI
• Qualcomm
• Raytheon
• Samsung
• Sao Paulo Military Police Force
• Tait
• Tecore
• TeleCommunication Systems (TCS)
• Thales
• US Army
• US Department of Defense
• Verizon Wireless

Contact sales@reportsandreports.com for further information.

World Blood Banking Market Key Players-Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Buy a copy of this report @ http://www.reportsnreports.com/reports/215136-competitive-intelligence-world-blood-banking-market-key-players-strategic-assessments-of-major-suppliers-and-emerging-market-entrants.html.

Table of Contents
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Gen-Probe
Grifols
Immucor
Innogenetics
Ortho-Clinical Diagnostics
Orchid CellMark
Novartis Diagnostics
Proteome Sciences
Roche
Siemens
Tecan

Request a Sample of this report @ http://www.reportsnreports.com/contacts/question.aspx?name=215136 

Report Details:
Published: January 2013
No. of Pages: 50 
Price:Single User License:US$         Corporate User License:US$ 
 
  

Standoff Person-Borne and Vehicle-Borne Explosives & Weapon Detection: Technologies and Markets – 2012-2016

Terrorist attacks using Person-Borne IEDs (PBIED) and Vehicle-Borne IEDs (VBIED) remain a global problem, and have driven a growing number of homeland security and defense organizations to procure PBIED & VBIED standoff detection equipment.

The purpose of standoff PBIED & VBIED detection technologies is to determine at a safe distance if a human subject or a vehicle are carrying concealed explosives or weapons. Concealed weapons detection is perceived as one of the greatest challenges facing the counter-terror and military communities today. The threat posed by suicide bombers is the key to the emergence of transformational counter-terror technologies and tactics. The maturity and deployment of advanced standoff detection technologies capable of detecting suicide and other terrorists at a safe distance will change the landscape of homeland security and asymmetric warfare.

Buy a copy of this report @ http://www.reportsnreports.com/reports/215278-standoff-person-borne-and-vehicle-borne-explosives-weapon-detection-technologies-and-markets-2012-2016.html 

In the new Standoff Person-Borne and Vehicle-Borne Explosives & Weapon Detection: Technologies and Markets – 2012-2016 report HSRC analysts forecast that the market will grow at a CAGR of 33%.
The report, segmented into 93 sub-markets, offers for each sub-market 2011 data and 2012-2016 forecasts and analysis. In 193 pages, 62 tables and 126 figures, the report analyses and projects the 2012-2016 market and technologies from several perspectives, including:

• Market forecast by customer sector (e.g. transportation, defense, secured facilities)
• Market segmented by Systems sales vs. Service, upgrades & refurbishing market
• 5 regional markets
• The standoff detection industry: vendors , products, prices and RDT&E programs
• Market analysis (e.g., market drivers & inhibitors, SWOT analysis)
• Business environment (e.g., competitive analysis)
• Current and pipeline technologies
• Business opportunities and challenge

Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215278http://www.reportsnreports.com/contacts/RequestSample.aspx?name=215278

Competitive Intelligence: World Clinical Chemistry and Immunodiagnostics Market Key Players-Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new report from Venture Planning Group provides strategic assessments of major clinical chemistry and immunodiagnostic product suppliers and emerging market entrants.The report presents strategic profiles of 25 current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies

Buy a copy of this report @ http://www.reportsnreports.com/reports/215138-competitive-intelligence-world-clinical-chemistry-and-immunodiagnostics-market-key-players-strategic-assessments-of-major-suppliers-and-emerging-market-entrants.html 

Table of Contents
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

Request  a Sample of this report @ http://www.reportsnreports.com/contacts/question.aspx?name=215138 

Contact sales@reportsandreports.com for further information.